The mitochondrial oxidative phosphorylation ... nuclear gene mutations that affect various protein subunits of complex I and complex II have been identified (Fig. 5). This knowledge is not ...
The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...